Identification of a Hormone Response Element That Mediates Suppression of APOF by LXR and PPARα Agonists.

Yan Liu,Lahoucine Izem,Richard E. Morton
DOI: https://doi.org/10.1016/j.bbalip.2019.158583
IF: 5.228
2019-01-01
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
Abstract:Apolipoprotein F (ApoF) regulates cholesteryl ester transfer protein activity. We previously observed that hepatic APOF mRNA levels are decreased by high fat, cholesterol-enriched diets. Here we show in human liver C3A cells that APOF mRNA levels are reduced by agonists of LXR and PPAR alpha nuclear receptors. This negative regulation requires co-incubation with the RXR agonist, retinoic acid. Bioinformatic analysis of the similar to 2 kb sequence upstream of the APOF promoter identified one potential LXR and 4 potential PPAR alpha binding sites clustered between nucleotides - 2007 and -1961. ChIP analysis confirmed agonist-dependent binding of LXR alpha, PPAR alpha, and RXR alpha to this hormone response element complex (HREc). A luciferase reporter containing the 2 kb 5' APOF sequence was negatively regulated by LXR and PPAR alpha ligands as seen in cells. This regulation was maintained in constructs lacking the similar to 1700 nucleotides between the HREc and the APOF proximal promoter. Mutations of the HREc that disrupted LXR alpha and PPAR alpha binding led to the loss of reporter construct inhibition by agonists of these nuclear receptors. siRNA knockdown studies showed that APOF gene regulation by LXR alpha or PPAR alpha agonists did not require an interaction between these two nuclear receptors. Thus, APOF is subject to negative regulation by agonist-activated LXR or PPAR alpha nuclear receptors binding to a regulatory element similar to 1900 bases 5' to the APOF promoter. High fat, cholesterol-enriched diets likely reduce APOF gene expression via these receptors interacting at this regulatory site.
What problem does this paper attempt to address?